Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
entrectinib (Rozlytrek) (1 trial)
pac-1 (1 trial)
Melanoma (Phase 2)
Uveal Neoplasms (Phase 2)
Trials (1 total)
Trial APIs (2 total)